Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 20751-20800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06245512
Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood
N/ARecruiting
250 participants
Started: Jul 31, 2024 · Completed: Mar 30, 2027
1 condition1 sponsor1 location
NCT06527131
Pulsed Electromagnetic Field Stimulation and Charcot Foot Ulcer
NARecruiting
34 participants
Started: Jul 31, 2024 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT06756698
The Intervention Effect and Potential Neural Mechanisms of Music Therapy in Children and Adolescents with Mood Disorders
NARecruiting
54 participants
Started: Jul 31, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06564974
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy.
N/ARecruiting
250 participants
Started: Jul 31, 2024 · Completed: Nov 30, 2030
1 condition1 sponsor25 locations
NCT06355063
CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
NARecruiting
30 participants
Started: Jul 31, 2024 · Completed: Oct 31, 2025
2 conditions1 sponsor3 locations
NCT06494189
Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
PHASE1Recruiting
29 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06254872
Qoyangnuptu: Peer Mentor
NARecruiting
4 participants
Started: Jul 31, 2024 · Completed: Oct 1, 2026
1 condition2 sponsors2 locations
NCT05628324
EMG-Controlled Game to Retrain Upper Extremity Muscle Activation Patterns Following Stroke
NARecruiting
62 participants
Started: Jul 31, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06216301
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
PHASE3Recruiting
734 participants
Started: Jul 31, 2024 · Completed: Oct 31, 2028
1 condition1 sponsor84 locations
NCT06514001
A Study of AMDX-2011P in Participants With Alzheimer's Disease
PHASE2Recruiting
25 participants
Started: Jul 31, 2024 · Completed: Mar 31, 2025
1 condition1 sponsor3 locations
NCT07008755
Clinical Trial of Pegylated Interferon α-2b Via Nebulization for Treatment of Hand, Foot, and Mouth Disease .
NARecruiting
90 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor5 locations
NCT06197386
Reliability and Validity of the Athlete Fear Avoidance Questionnaire in Turkish
N/ARecruiting
100 participants
Started: Jul 31, 2024 · Completed: Sep 1, 2024
1 condition2 sponsors1 location
NCT06350032
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
PHASE3Recruiting
20 participants
Started: Jul 31, 2024 · Completed: Nov 30, 2028
1 condition1 sponsor5 locations
NCT06073626
Addressing Genomic Disparities in Cancer Survivors
NARecruiting
428 participants
Started: Jul 31, 2024 · Completed: Aug 31, 2027
2 conditions3 sponsors2 locations
NCT06510153
Music Therapy and Pre-recorded Music on Patients and Caregivers in the Emergency Unit
NARecruiting
243 participants
Started: Jul 31, 2024 · Completed: Sep 30, 2025
3 conditions2 sponsors2 locations
NCT06542835
Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity
NARecruiting
6,000 participants
Started: Jul 31, 2024 · Completed: Jan 31, 2027
1 condition4 sponsors1 location
NCT06587425
The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
PHASE2Recruiting
50 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06464952
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
NARecruiting
30 participants
Started: Jul 31, 2024 · Completed: Sep 25, 2025
2 conditions1 sponsor1 location
NCT06517758
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.
PHASE3Recruiting
146 participants
Started: Jul 31, 2024 · Completed: May 27, 2032
1 condition1 sponsor87 locations
NCT05987592
BE WELL With Migraine: Brain Education and WELLness With Migraine
NARecruiting
286 participants
Started: Jul 31, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors3 locations
NCT06449937
Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
NARecruiting
130 participants
Started: Jul 31, 2024 · Completed: Jul 31, 2028
3 conditions2 sponsors6 locations
NCT06650397
Guatemala Biofortified Maize Study
NARecruiting
56 participants
Started: Jul 31, 2024 · Completed: Sep 30, 2026
2 conditions3 sponsors1 location
NCT06529367
Comparing a Home Vision Self-Assessment Test to Office-Based Snellen Visual Acuity in Myopic Children
N/ARecruiting
80 participants
Started: Jul 31, 2024 · Completed: Feb 1, 2025
3 conditions1 sponsor1 location
NCT06565377
Multimodal Biopsychosocial Teleprehabilitation for Total Knee Arthroplasty
NARecruiting
60 participants
Started: Jul 31, 2024 · Completed: Sep 30, 2026
1 condition3 sponsors2 locations
NCT06578767
Decompression of Pudendal and Inferior Cluneal Nerves Using Robot-assisted Laparoscopy for Entrapment Neuralgias : the X-DECO Study
N/ARecruiting
20 participants
Started: Jul 31, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06503211
On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma
PHASE1Recruiting
10 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06169514
Health Systems and Policy Contexts of Medical Oxygen
N/ARecruiting
1 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2027
3 conditions8 sponsors6 locations
NCT06497361
Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
EARLY_PHASE1Recruiting
30 participants
Started: Jul 31, 2024 · Completed: Jul 31, 2028
2 conditions2 sponsors1 location
NCT06058624
Assessing the Efficacy of an Acceptance-Based Digital Intervention for Veterans With Chronic Pain
NARecruiting
240 participants
Started: Jul 31, 2024 · Completed: Oct 31, 2027
1 condition3 sponsors3 locations
NCT06251713
Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery
NARecruiting
40 participants
Started: Jul 31, 2024 · Completed: Jul 31, 2026
4 conditions1 sponsor2 locations
NCT06107764
Cerebellar Modulation of Cognition in Psychosis
NARecruiting
95 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2029
4 conditions2 sponsors2 locations
NCT06211504
Sinus Tarsi Implant as an Adjuvant Procedure to Medial Displacement Calcaneal Osteotomy in the Treatment of Mobile Adult Acquired Flatfoot Deformity
PHASE4Recruiting
130 participants
Started: Jul 31, 2024 · Completed: Jul 31, 2028
3 conditions1 sponsor10 locations
NCT06502015
Biomarkers in Autoimmune Disease of Nervous System
N/ARecruiting
50,000 participants
Started: Jul 31, 2024 · Completed: Jul 31, 2027
11 conditions1 sponsor1 location
NCT06494423
Employment Support After Hematopoietic Stem Cell Transplantation
NARecruiting
35 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06499246
Parathyroid Allotransplant for Severe Refractory Hypoparathyroidism
NARecruiting
5 participants
Started: Jul 31, 2024 · Completed: Jul 31, 2028
1 condition3 sponsors1 location
NCT06454006
Effects of PBMT-sMF in Mechanically Ventilated Patients
NARecruiting
112 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06497387
Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease
EARLY_PHASE1Recruiting
30 participants
Started: Jul 31, 2024 · Completed: Jul 31, 2028
2 conditions2 sponsors1 location
NCT07010965
SAVE-PCI: NyokAssist™ Small-Bore VAD vs. IABP in Elective High-Risk PCI
NARecruiting
236 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor12 locations
NCT06388083
A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease
PHASE2/PHASE3Recruiting
60 participants
Started: Jul 31, 2024 · Completed: Jan 31, 2028
2 conditions1 sponsor14 locations
NCT06404086
RECOVER-SLEEP: Platform Protocol
PHASE2Recruiting
1,074 participants
Started: Jul 31, 2024 · Completed: Dec 31, 2025
4 conditions1 sponsor47 locations
NCT06129539
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)
PHASE3Recruiting
56 participants
Started: Jul 31, 2024 · Completed: Feb 29, 2028
1 condition1 sponsor37 locations
NCT06519760
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
NARecruiting
200 participants
Started: Jul 30, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06578520
Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure
PHASE4Recruiting
31 participants
Started: Jul 30, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06505395
A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
PHASE2Recruiting
90 participants
Started: Jul 30, 2024 · Completed: Aug 1, 2028
1 condition1 sponsor1 location
NCT06681311
The Effects of Core and Shoulder Stabilization Exercises on Athletic Performance and Injury Risk in Master Swimmers
NARecruiting
40 participants
Started: Jul 30, 2024 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT06675214
Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.
PHASE3Recruiting
586 participants
Started: Jul 30, 2024 · Completed: Jul 31, 2030
2 conditions1 sponsor1 location
NCT06837701
The True Face of the Pyramid; Physical Activity Level and Cardiovascular Risk in Patients With Breast Cancer
N/ARecruiting
50 participants
Started: Jul 30, 2024 · Completed: Aug 1, 2025
3 conditions1 sponsor1 location
NCT06516198
Auricular Acupressure in Prehabilitation
NARecruiting
40 participants
Started: Jul 30, 2024 · Completed: Jun 20, 2027
8 conditions1 sponsor1 location
NCT06483321
Effect of Creatine Supplementation on Physical Performance in Vegan Subjects
NARecruiting
20 participants
Started: Jul 30, 2024 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06585618
A Multicenter Pediatric Deep Brain Stimulation Registry
N/ARecruiting
100 participants
Started: Jul 30, 2024 · Completed: Jul 30, 2029
9 conditions1 sponsor1 location